Factorial designs in pharmaceutical preformulation studies. II. Studies on drug stability and compatibility in the solid state.
作者信息
Ahlneck C, Waltersson J O
出版信息
Acta Pharm Suec. 1986;23(3):139-50.
PMID:3766159
Abstract
摘要
相似文献
1
2
3
Methods for the evaluation of solid state stability and compatibility between drug and excipient.药物与辅料之间固态稳定性及相容性的评估方法。
Acta Pharm Suec. 1985;22(6):305-14.
4
Drug-excipient compatibility screening--role of thermoanalytical and spectroscopic techniques.药物-赋形剂相容性筛选--热分析和光谱技术的作用。
J Pharm Biomed Anal. 2014 Jan;87:82-97. doi: 10.1016/j.jpba.2013.06.016. Epub 2013 Jun 21.
5
A stability-indicating HPLC method for the determination of glucosamine in pharmaceutical formulations.一种用于测定药物制剂中氨基葡萄糖的稳定性指示高效液相色谱法。
J Pharm Biomed Anal. 2004 May 28;35(3):625-31. doi: 10.1016/j.jpba.2004.01.021.
6
Issues in evaluation of bioanalytical method selectivity and drug stability.生物分析方法选择性和药物稳定性评估中的问题
J Pharm Biomed Anal. 1995 Dec;14(1-2):23-31. doi: 10.1016/0731-7085(95)01634-1.
7
Non-isothermal stability testing of drug substances in the solid state.药物固态的非等温稳定性测试
Acta Pharm Suec. 1987;24(3):115-22.
8
Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form.了解药物-辅料相容性：固体剂型中化合物A的氧化
Pharm Dev Technol. 2009;14(5):556-64. doi: 10.1080/10837450903182140.
9
A factorial design for compatibility studies on preformulation work.用于制剂前研究兼容性研究的析因设计。
Pharm Acta Helv. 1975;50(4):88-91.
10
Solid state chemical instability of an asparaginyl residue in a model hexapeptide.一种模型六肽中天冬酰胺残基的固态化学不稳定性。
J Pharm Sci Technol. 1994 May-Jun;48(3):167-23.
引用本文的文献
1
Issues to consider in the pharmaceutical development of a cardiovascular polypill.心血管复方制剂药物研发中需考虑的问题。
Nat Clin Pract Cardiovasc Med. 2009 Feb;6(2):112-9. doi: 10.1038/ncpcardio1424. Epub 2008 Dec 23.
Zotero 插件